Mary Rinella to Pyridazines
This is a "connection" page, showing publications Mary Rinella has written about Pyridazines.
Connection Strength
0.442
-
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management. Nat Rev Gastroenterol Hepatol. 2026 Jun; 23(6):460-474.
Score: 0.237
-
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 02 08; 390(6):497-509.
Score: 0.205